The aims of this study were as follows: to confirm that the presence of estrogen (ER) and
progesterone (PgR) receptors is an indicator of clinical behavior of human breast cancer …

Our present state of knowledge regarding estrogen and progesterone receptors (ER and
PgR) has led to changes in. treatment strategies: patients without receptors in their tumor …

To determine the correlation between the estrogen-receptor status and responses to
chemotherapy or hormonal therapy, we retrospectively analyzed the clinical data of 143 …

The presence of progesterone receptors was found to be associated with a favorable
prognosis in 98 patients with primary breast cancer. The occurrence of metastases was 3.6 …

In the last two decades, the prognostic role of the steroid hormone receptors has been the
subject of a myriad of publications. Nevertheless, its relevance after long-term follow-up is …

Estrogen and progestin receptor levels (ER and PgR) in tumors from 506 patients with
primary breast cancer diagnosed in 1979, 1980, and 1981 were measured by a Scatchard …

Estradiol receptor alone or estradiol and progesterone receptors (ER, PgR) have been
measured in tumors from 307 women who were treated for primary breast adenocarcinoma …

It has been demonstrated that progesterone receptor (PR) is at least as valuable as estrogen
receptor (ER) for predicting the outcome in breast cancer patients. Retrospective analysis …

The influence of estrogen receptor status on response rate to endocrine therapy in 85
patients with metastatic breast cancer was determined in a retrospective study. The specific …

The measurement of cytoplasmic estrogen receptor in tumors from patients with breast
cancer is now well established. Potential uses include prognosis of early recurrence …